Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions
By: Hinsley EE, Hunt S, Hunter KD, Whawell SA, Lambert DW.

Oral Disease Research Group, School of Clinical Dentistry, University of Sheffield S10 2TA, UK.
Int J Cancer. 2012 Jan 1; 130(1):40-7. doi: 10.1002/ijc.25968. Epub 2011 Apr 13.

Abstract

The invasion and migration of cancer cells is increasingly recognised to be influenced by factors derived from adjacent tumour-associated stroma. The contextual signals regulating stromal-tumour interactions, however, remain poorly understood. Here, we identify a role for endothelin-1 (ET-1), a mitogenic peptide elevated in a number of malignancies, in promoting pro-metastatic cross-talk between head and neck cancer cells and adjacent fibroblasts. We demonstrate that treatment of oral fibroblasts with ET-1 activates ADAM17-mediated release of epidermal growth factor receptor (EGFR) ligands, triggering EGFR signalling and increased motility in neighbouring head and neck cancer cells. ET-1-mediated paracrine transactivation of EGFR also increased cyclo-oxygenase-2 levels in the cancer cells, providing a molecular insight into the mechanisms by which the elevated levels of ET-1 observed in head and neck cancers may contribute to disease progression.

Copyright © 2011 UICC.

PMID: 21491424 [PubMed - indexed for MEDLINE] Source: National Library of Medicine.







Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements